2:34 PM Marksans Pharma hits 52-week high after USFDA issues EIR for Goa facility Shares of Marksans Pharma  soared up to 1.98 per cent at Rs 220.14 per share on the BSE in Tuesday’s intraday trade. This came after the pharmaceutical company on Tuesday said that it has received an establishment inspection report (EIR) from